SENS PubMed Publication Search
Is the p3 Peptide (Aβ17-40, Aβ17-42) Relevant to the Pathology of Alzheimer's Disease?1
J Alzheimers Dis. 2020;74(1):43-53. doi: 10.3233/JAD-191201.
Ariel J Kuhn 1, Jevgenij Raskatov 1
Abstract:
...An alternative cleavage product of the Amyloid-β protein precursor, called the p3 peptide, which has also been isolated from the brains of AD patients, has been largely absent from most Aβ-related studies. Typically referred to as non-amyloidogenic and even suggested as neuroprotective, the p3 peptide has garnered little attention aside from some conflicting findings on cytotoxicity and potential self-assembly to form higher order aggregates. Herein, we report an extensive analysis of the findings surrounding p3 and offer some evidence as to why it may not be as innocuous as previously suggested.
PMID: 32176648
Free Full-Text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443050/
Tags: Alzheimer’s, p3, protein aggregates, review